Medicare Enrolled

Dr. Renuka Borra, M.D.

Medical Oncology · Odessa, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
301 N WASHINGTON AVE, Odessa, TX 79761
4323558275
In practice since 2006 (19 years)
NPI: 1386686558 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borra

Dr. Renuka Borra is a medical oncology specialist in Odessa, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Borra performed 57,545 Medicare services across 3,218 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borra received a total of $92 from 4 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 18% volume in TX $92 industry payments

Medicare Practice Summary

Medicare Utilization ↗
57,545
Medicare services
Top 18% in TX for medical oncology
3,218
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,029 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 18,000 $0 $2
Anti-nausea injection (fosaprepitant) 10,500 $0 $5
Contrast dye for imaging (iodine-based) 8,955 $0 $3
Paclitaxel chemotherapy injection 6,936 $0 $8
Dexamethasone injection (steroid) 2,402 $0 $1
Injection, granisetron hydrochloride, 100 mcg 1,170 $0 $24
Blood draw (venipuncture) 1,078 $8 $20
Anti-nausea injection (Aloxi/palonosetron) 1,000 $1 $114
Complete blood count (CBC) with differential 954 $8 $36
Comprehensive metabolic blood panel 637 $10 $64
Injection, leucovorin calcium, per 50 mg 469 $3 $25
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 383 $21 $157
Office visit, established patient (30-39 min) 319 $92 $368
Administration of chemotherapy into vein, 1 hour or less 270 $97 $707
Magnesium level test 251 $7 $29
Injection, fluorouracil, 500 mg 246 $2 $13
Office visit, established patient (20-29 min) 215 $61 $250
Injection, carboplatin, 50 mg 213 $2 $300
Injection, magnesium sulfate, per 500 mg 198 $1 $6
Lactate dehydrogenase (enzyme) level 164 $6 $31
Reticulated (young) platelet measurement 162 $35 $143
Injection, zoledronic acid, 1 mg 157 $6 $431
Infusion into a vein for hydration, each additional hour 155 $10 $75
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 153 $46 $313
Ferritin level test (iron stores) 148 $13 $60
Administration of chemotherapy into vein, each additional hour 145 $21 $161
Iron level test 139 $6 $27
Iron binding capacity test 139 $8 $35
Leuprolide acetate (for depot suspension), 7.5 mg 120 $134 $3,675
Injection of additional new drug or substance into vein 118 $11 $108
Injection, diphenhydramine hcl, up to 50 mg 117 $1 $7
Administration of additional new drug or substance into vein, 1 hour or less 116 $48 $344
Basic metabolic blood panel 89 $8 $49
Infusion, normal saline solution , 1000 cc 87 $2 $19
Ct scan of chest with contrast 85 $46 $821
Drug injection, under skin or into muscle 85 $11 $96
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 75 $15 $100
CT scan of abdomen and pelvis with contrast 74 $160 $1,067
Unclassified drugs 71 $1 $8
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 69 $24 $145
New patient office visit, complex (60-74 min) 63 $158 $709
Microscopic examination for white blood cells with manual cell count 61 $4 $22
Complete blood count (CBC), automated 61 $6 $34
Blood creatinine level 57 $5 $31
Urea nitrogen level to assess kidney function, quantitative 57 $4 $24
Red blood count automated, with additional calculations 56 $5 $26
Irrigation of implanted venous access drug delivery device 53 $17 $114
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 41 $20 $128
Carcinoembryonic antigen (cea) protein level 40 $18 $99
PSA test (prostate cancer screening) 40 $18 $94
Administration of additional new drug or substance into vein using push technique 37 $41 $289
CT scan of chest, without contrast 35 $30 $686
Office visit, established patient (10-19 min) 35 $36 $150
Ct scan of abdomen and pelvis without contrast 33 $76 $560
Injection, methylprednisolone sodium succinate, up to 125 mg 32 $4 $25
Stool analysis for blood, by peroxidase activity 31 $4 $16
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 27 $124 $500
Injection of drug or substance into vein 26 $27 $247
Infusion, normal saline solution, sterile (500 ml = 1 unit) 23 $1 $19
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 21 $15 $94
Office visit, established patient, complex (40-54 min) 20 $134 $496
Infusion into a vein for hydration, 31-60 minutes 18 $25 $256
Ct scan of soft tissue of neck with contrast 14 $65 $658
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
89.2% medium
9.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$92
Total received (2021-2024)
Avg $23/year across 4 years
Bottom 7% in TX for medical oncology
4
Companies
4
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$80 (87.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (12.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18
2023
$46
2022
$16
2021
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$46
E.R. Squibb & Sons, L.L.C.
$18
Novartis Pharmaceuticals Corporation
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 87.1% of total payments
Associated products mentioned in payments ›
KISQALI · KRAZATI · LIBTAYO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $0 per 100 Medicare services performed
Looking for a medical oncology specialist in Odessa?
Compare medical oncologists in the Odessa area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
5
Per 100K population
3.1
County median income
$71,031
Nearest hospital
MEDICAL CENTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Borra is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Borra experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Borra performed 18,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borra receive payments from pharmaceutical companies?
Yes. Dr. Borra received a total of $92 from 4 companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borra's costs compare to other medical oncologists in Odessa?
Dr. Borra's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →